This contract expires in 261 days (Jan 3, 2027).
FIRM FIXED PRICE
TAKEDA PHARMACEUTICALS AMERICA INC - ADZYNMA 1500IU INJ,LYPHL.
PIID: 36C26026F0130
Signed Date: Jan 2, 2026Effective Date: Jan 4, 2026End Date: Closes in 261 days
Key Details
Description
ADZYNMA 1500IU INJ,LYPHL.
Contractor Information
Contractor: TAKEDA PHARMACEUTICALS AMERICA INC
UEI: DDEVYUAXJ624
CAGE Code: 4DE70
Location: DEERFIELD, IL
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.